Drugs / DTaP-Hib-IPV
DTaP-Hib-IPV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy4 trials | ||||||
| Phase 2 | NCT00488683 Background | Jul 2007 → May 2009 | meningococcal infection | Novartis Vaccines | Completed | No outcome recorded |
| Phase 2 | NCT00381615 Background | Sep 2006 → Jul 2007 | — | Novartis Vaccines | Completed | No outcome recorded |
| Phase 2 | NCT00310856 Background | Jun 2005 → Nov 2006 | meningococcal meningitis | Novartis Vaccines | Completed | No outcome recorded |
| Phase 2 | NCT00262002 Background | Sep 2004 → Jul 2005 | meningococcemia | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTaPHibIPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00262002 ↗ |
| Known as | Combined diphtheria, tetanus toxoid, acellular pertussis, Haemophilus influenzae type B and inactivated polio vaccine; Pediacel | “Combined diphtheria, tetanus toxoid, acellular pertussis, Haemophilus influenzae type B and inactivated polio vaccine; Pediacel” NCT00488683 ↗ |
| Known as | Diphtheria, Tetanus, acellular Pertussis, H. Influenzae type b, Inactivated Poliovaccine | “DTaPHibIPV (Diphtheria, Tetanus, acellular Pertussis, H. Influenzae type b, Inactivated Poliovaccine)” NCT00262002 ↗ |
| Modality | Vaccine | “Diphtheria, Tetanus, acellular Pertussis, H. Influenzae type b, Inactivated Poliovaccine” NCT00262002 ↗ |
| Route | Intramuscular | “DTaPHibIPV at 2, 3, 4 months of age, administered IM in the anterolateral area of the left thigh” NCT00262002 ↗ |